Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer.
Pötter R, Gnant M, Kwasny W, Tausch C, Handl-Zeller L, Pakisch B, Taucher S, Hammer J, Luschin-Ebengreuth G, Schmid M, Sedlmayer F, Stierer M, Reiner G, Kapp K, Hofbauer F, Rottenfusser A, Pöstlberger S, Haider K, Draxler W, Jakesz R; Austrian Breast and Colorectal Cancer Study Group. Pötter R, et al. Among authors: handl zeller l. Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):334-40. doi: 10.1016/j.ijrobp.2006.12.045. Epub 2007 Mar 23. Int J Radiat Oncol Biol Phys. 2007. PMID: 17363187 Clinical Trial.
Breast-conserving surgery for T3/T4 breast cancer: an analysis of 196 patients.
Fitzal F, Riedl O, Wutzl L, Draxler W, Rudas M, Pluschnig U, Handl-Zeller L, Dubsky P, Bachleitner-Hofmann T, Steger G, Jakesz R, Gnant M. Fitzal F, et al. Among authors: handl zeller l. Breast Cancer Res Treat. 2007 May;103(1):45-52. doi: 10.1007/s10549-006-9325-6. Epub 2007 Apr 7. Breast Cancer Res Treat. 2007. PMID: 17417725
Partial breast irradiation for locally recurrent breast cancer within a second breast conserving treatment: alternative to mastectomy? Results from a prospective trial.
Kauer-Dorner D, Pötter R, Resch A, Handl-Zeller L, Kirchheiner K, Meyer-Schell K, Dörr W. Kauer-Dorner D, et al. Among authors: handl zeller l. Radiother Oncol. 2012 Jan;102(1):96-101. doi: 10.1016/j.radonc.2011.07.020. Epub 2011 Sep 8. Radiother Oncol. 2012. PMID: 21907439 Clinical Trial.
Long-term results (10 years) of intensive breast conserving therapy including a high-dose and large-volume interstitial brachytherapy boost (LDR/HDR) for T1/T2 breast cancer.
Resch A, Pötter R, Van Limbergen E, Biber E, Klein T, Fellner C, Handl-Zeller L, Langbauer G, Schürer-Waldheim H, Staffen A, Jakesz R, Kubista E, Lehr S, Seitz W. Resch A, et al. Among authors: handl zeller l. Radiother Oncol. 2002 Apr;63(1):47-58. doi: 10.1016/s0167-8140(02)00022-1. Radiother Oncol. 2002. PMID: 12065103
Teleradiotherapy of joints in rheumatoid arthritis: lack of efficacy.
Graninger M, Handl-Zeller L, Hohenberg G, Staudenherz A, Kainberger F, Graninger W. Graninger M, et al. Among authors: handl zeller l. Ann Rheum Dis. 2005 Jan;64(1):138-40. doi: 10.1136/ard.2004.021766. Ann Rheum Dis. 2005. PMID: 15608312 Free PMC article. Clinical Trial.
32 results